To gain insights into essential binding sites in a different cell lineage, we performed the same screening experiment in the LNCaP prostate cancer cell line, where FOXA1 is also known to be essential (SI Appendix, Fig. S4 A–C). Here, FOXA1 is linked to prostate carcinoma.